Malignancy Rates and Diagnostic Performance of the Bosniak Classification for the Diagnosis of Cystic Renal Lesions in Computed Tomography - a Systematic Review and Meta-analysis
Overview
Authors
Affiliations
Objective: To systematically review the literature on the Bosniak classification system in CT to determine its diagnostic performance to diagnose malignant cystic lesions and the prevalence of malignancy in Bosniak categories.
Methods: A predefined database search was performed from 1 January 1986 to 18 January 2016. Two independent reviewers extracted data on malignancy rates in Bosniak categories and several covariates using predefined criteria. Study quality was assessed using QUADAS-2. Meta-analysis included data pooling, subgroup analyses, meta-regression and investigation of publication bias.
Results: A total of 35 studies, which included 2,578 lesions, were investigated. Data on observer experience, inter-observer variation and technical CT standards were insufficiently reported. The pooled rate of malignancy increased from Bosniak I (3.2 %, 95 % CI 0-6.8, I = 5 %) to Bosniak II (6 %, 95 % CI 2.7-9.3, I = 32 %), IIF (6.7 %, 95 % CI 5-8.4, I = 0 %), III (55.1 %, 95 % CI 45.7-64.5, I = 89 %) and IV (91 %, 95 % CI 87.7-94.2, I = 36). Several study design-related influences on malignancy rates and subsequent diagnostic performance indices were identified.
Conclusion: The Bosniak classification is an accurate tool with which to stratify the risk of malignancy in renal cystic lesions.
Key Points: • The Bosniak classification can accurately rule out malignancy. • Specificity remains moderate at 74 % (95 % CI 64-82). • Follow-up examinations should be considered in Bosniak IIF and Bosniak II cysts. • Data on the influence of reader experience and inter-reader variability are insufficient. • Technical CT standards and publication year did not influence diagnostic performance.
Chen K, Zhao J, Sasani A, Sabour R, Cho H, Bansal R Radiol Case Rep. 2025; 20(3):1726-1735.
PMID: 39868056 PMC: 11760803. DOI: 10.1016/j.radcr.2024.12.044.
He H, Jin X, Liu Y, Chen Y, Vaishnani D, Xia Y Abdom Radiol (NY). 2024; .
PMID: 39694945 DOI: 10.1007/s00261-024-04744-4.
Radiomics for differential diagnosis of Bosniak II-IV renal masses via CT imaging.
Zhao X, Yan Y, Xie W, Qin Z, Zhao L, Liu C BMC Cancer. 2024; 24(1):1508.
PMID: 39643905 PMC: 11622457. DOI: 10.1186/s12885-024-13283-6.
Contrast enhanced ultrasound of cystic renal lesions, from diagnosis up to treatment.
Spiesecke P, Thiemann J, Conen P, Clevert D Clin Hemorheol Microcirc. 2024; 88(s1):S21-S33.
PMID: 39365320 PMC: 11612966. DOI: 10.3233/CH-248102.
Yu T, Yan Z, Li Z, Yang M, Yu Z, Chen Y Transl Androl Urol. 2024; 13(6):949-961.
PMID: 38983472 PMC: 11228685. DOI: 10.21037/tau-23-656.